PLEGRIDY

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug PLEGRIDY contains one active pharmaceutical ingredient (API):

1	Peginterferon beta-1a UNII I8309403R0 - PEGINTERFERON BETA-1A
	Peginterferon beta-1a is an interferon conjugated to a single, linear 20 kDa methoxy poly(ethyleneglycol) molecule at the alpha-amino group of the N-terminal amino acid residue. A definitive mechanism of action of peginterferon beta-1a in multiple sclerosis (MS) is not known. Peginterferon beta-1a binds to the type I interferon receptor on the surface of cells and elicits a cascade of intracellular events leading to the regulation of interferon-responsive gene expression.
	Read more about Peginterferon beta-1a

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PLEGRIDY Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L03AB13		L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10212L, 10218T, 10220X
BR	Câmara de Regulação do Mercado de Medicamentos	538317050001707, 538317050001807, 538317050001907, 538317050002007
CA	Health Products and Food Branch	02444399, 02444402
EE	Ravimiamet	1657874, 1657931, 1657942, 1657953, 1657964, 1657975
ES	Centro de información online de medicamentos de la AEMPS	114934001, 114934002, 114934003, 114934005
FI	Lääkealan turvallisuus- ja kehittämiskeskus	373251, 522427
FR	Base de données publique des médicaments	60665360, 61349130, 66988648, 69002701
GB	Medicines & Healthcare Products Regulatory Agency	279523, 279529, 279539, 280183, 393564
IE	Health Products Regulatory Authority	88461, 88462, 89061
IL	מִשְׂרַד הַבְּרִיאוּת	7630, 7632
IT	Agenzia del Farmaco	043527011, 043527023, 043527035, 043527047, 043527050, 043527062, 043527074, 043527086
LT	Valstybinė vaistų kontrolės tarnyba	1073915, 1073916, 1073917, 1073918, 1073919, 1073920, 1091574, 1091575
NL	Z-Index G-Standaard, PRK	125253, 125261, 125288, 125296
NZ	Medicines and Medical Devices Safety Authority	17464, 17466
PL	Rejestru Produktów Leczniczych	100325822, 100325839
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64761001, W65152001, W65152002, W65153001, W65153002, W65154001
TN	Direction de la Pharmacie et du Médicament	10913021H, 10913022H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699783950088, 8699783950095
US	FDA, National Drug Code	64406-011, 64406-015
ZA	Health Products Regulatory Authority	48/32.16/0426, 48/32.16/0427, 48/32.16/0428